Crosstalk between Insulin/IGF-1 and GPCR Signaling Systems: A Novel Target for the Anti-diabetic Drug Metformin in Pancreatic Cancer

Por Rozengurt, Enrique, Sinnett-Smith, James, Kisfalvi, Krisztina
Publicado em 2010

Induced Overexpression of Protein Kinase D1 Stimulates Mitogenic Signaling in Human Pancreatic Carcinoma PANC-1 Cells

Por Kisfalvi, Krisztina, Hurd, Cliff, Guha, Sushovan, Rozengurt, Enrique
Publicado em 2010

Metformin Disrupts Crosstalk Between G protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth

Por Kisfalvi, Krisztina, Eibl, Guido, Sinnett-Smith, James, Rozengurt, Enrique
Publicado em 2009

Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK

Por Sinnett-Smith, James, Kisfalvi, Krisztina, Kui, Robert, Rozengurt, Enrique
Publicado em 2012

Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade

Por Varga, Gábor, Kisfalvi, Krisztina, Pelosini, Iva, D'Amato, Massimo, Scarpignato, Carmelo
Publicado em 1998

Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells

Por Soares, Heloisa P., Ni, Yang, Kisfalvi, Krisztina, Sinnett-Smith, James, Rozengurt, Enrique
Publicado em 2013